Model Number PP6-530-0027-US |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Corneal Clouding/Hazing (1878); Loss of Vision (2139)
|
Event Date 06/14/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
The inlay remains implanted and therefore is not available for evaluation.The device history record review of the manufacturing lot was performed and there were no discrepancies or unusual findings related to the reported issue.Corneal haze and decreased vision are listed in the device labeling as known potential risks.(b)(4).The inlay remains implanted.
|
|
Event Description
|
The subject was enrolled in the ide clinical trial and underwent uneventful implantation of the investigational corneal inlay in the right eye on (b)(6) 2012.The patient followed the study protocol as directed.Five years postoperatively, the patient presented with central corneal haze, grade ii in the operative eye.The patient's best corrected distance visual acuity (bcdva) decreased from 55 letters (preoperatively) to 38 at onset.The patient is being treated with topical steroids and the haze has improved slightly.At last examination on (b)(6) 2017, bcdva was 20/100, however this is confounded because the patient is developing cataracts.
|
|
Manufacturer Narrative
|
The explanted inlay was discarded by the facility and is not available for evaluation.(b)(4).
|
|
Event Description
|
The inlay was explanted on (b)(6) 2017 in order to address recurrent haze.Additional information has been requested.
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Event Description
|
Clarification for the reported event was requested from the surgeon, who provided the following additional information.At last examination on (b)(6) 2017, bcdva was 20/25+.
|
|
Manufacturer Narrative
|
Complaint reference number: (b)(4).
|
|
Event Description
|
Patient follow-up was requested from the surgeon, who provided the following additional information.The patient presented with central and peripheral grade 2 haze at the 60 month follow-up visit.The patient had no prior relevant medical or ocular history.The patient was examined 1-day post inlay explant, at which time haze was still present.At last examination on (b)(6) 2017, bcdva was 20/40 (cataract present), but the status of the corneal haze was not provided.Additional information has been requested.The corneal inlay is not suspected as a contributing factor in the cataract progression (locs iii grading: opalescence/color - grade 3).The cataract will be addressed at a later time once the eye heals.
|
|
Search Alerts/Recalls
|